REV: Responsibly and reliably powering industry
With a focus on the creation of innovative technology and forward-thinking practical solutions, REV offers flexible, durable, reliable
Kramer Mazda: The largest Mazda dealership in Western Canada
The largest Mazda dealership in Calgary and Western Canada, for over 40 years Kramer Mazda has been developing German-Canadian Care Home: An innovative new vision for elder care
Providing compassionate care to seniors in Vancouver for over 50 years, the German-Canadian Care Home is part of Hinton Scaffold Solutions: Utilizing innovate technologies to create safer worksites
With many years of experience in the heavy industrial scaffold industry, Ontario-based Hinton Scaffold Solutions provides highly innovative Alberta Veterinary Laboratories / Solvet: Supporting Canada’s food
Founded in 2009, Western Canadian family-owned pharmaceutical manufacturer Alberta Veterinary Laboratories manufactures and provides efficacious and cost-effective animal Sodexo Canada: The global leader who believes the difference a day makes
Founded in Marseille in 1966, and now operating in 53 countries, Sodexo provides facilities services that drive positive Barclay Restorations DKI: The longest running insurance restoration company in Greater Vancouver
Locally owned-and operated and serving Metro Vancouver and the Fraser Valley, Barclay Restorations DKI is a full-service restoration CDW Canada: Helping small businesses use IT security to prepare, defend, and respond
Established in 2003, CDW Canada is a leading provider of technology solutions for business, government, education, and healthcare,-
Taking charitable giving to the next level
Empowering employees to support the causes that matter most to them is the best way to maximize charitable Lots of money seeking company acquisitions – The case of private equity
At this time, there is more money in the system than anyone can imagine. It is estimated that There’s optimism amid instability in the Canadian construction landscape
The last year has been among the most expensive on record for many Canadians. Families and those on Washed up elites need to stop lecturing the people
The ramblings of ex-Prime Ministers, Presidents and CEOs is a feature of all political life, history and cultures. The political timing of Finland’s admission into NATO
It has been a few weeks since the world watched the proverbial ink of approval dry on Finland’s How to manage the stress of making the right business decisions
It can be stressful when you have to make important decisions regarding your business. We all want to Reclaiming Canada’s key service export: Tourism
Tourism is an increasingly dynamic sector of the global economy; pre-2019 tourism was a $1.4 trillion industry generating Concerning signs for Canada’s construction sector in 2023
Coming into 2022, construction contractors had never been more optimistic about the state of the industry. Independent Contractors
HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA (CANADA) FOR THE DISTRIBUTION AND LICENSING RIGHTS OF ALOXI® (PALONOSETRON HYDROCHLORIDE) IN CANADA
Helsinn Group and Purdue Pharma (Canada) has announced that they have signed a distribution and licence agreement granting Purdue Pharma (Canada) exclusive rights to distribute, promote, market and sell ALOXI® (palonosetron hydrochloride) in Canada.
ALOXI® is an anti-emetic (5-HT3 receptor antagonist) authorized for sale by Health Canada in adults for the prevention of chemotherapy-induced nausea and vomiting (CINV)I.
ALOXI® is approved in over 70 countries worldwide, including the United States, European countries and Japan.
Riccardo Braglia, Helsinn Group Vice Chairman and CEO, commented: “ALOXI® has helped to provide relief from CINV to patients across the world and, through this agreement with Purdue Pharma (Canada) we hope to extend its benefits to a greater number of patients in Canada. We are also pleased to be able to broaden our relationship with Purdue/Mundipharma Network, a trusted partner that we work with in many countries across 5 continents and look forward to working with them in Canada”.
Dr. Craig Landau, Purdue Pharma (Canada) CEO added: “Patients deserve access to medicines and treatments that help them manage their symptoms so they can participate fully in the things that matter most to them. Purdue Pharma (Canada) already offers medicines that benefit patients with cancer who also suffer from pain. Now, we can also help those who suffer from CINV. ALOXI® is a natural addition to our expanding portfolio.”
- Read the current edition
- Recent posts
